Tag: combination

New York, NY, June 02, 2026 (GLOBE NEWSWIRE) -- AmperCap Acquisition Company (the “Company”) announced today the pricing of its initial public offering of 12,500,000 units, at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Stock Market LLC (“Nasdaq”) and begin trading on Wednesday, June 3, 2026, under the ticker symbol “APMCU.” Each unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company’s initial business combination. Once the securities constituting the units begin separate trading, the ordinary shares and rights are expected to be listed on Nasdaq under the symbols “APMC” and “APMCR,” respectively. The offering is expected to close on June 4, 2026, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 1,875,000 units at the initial public offering price to cover over-allotments, if any.

WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in June:

NULISA™ DBS Extraction Kit recovers proteins from dried blood spot and dried plasma spot microsamples collected on leading third-party remote sampling devices 

The appointment expands Callan Family Office’s capabilities at the intersection of philanthropy, wealth planning, and family legacy.